At least two new players Max India and Fortis, are set to open their facilities in the first half of the new year. ITS THE bugbear of the Indian drug industry. Key legislation that has the potential to alter its fortune is taking its own time coming. As for Y2K, the Vajpayee government did not take a single decision on the contentious issues of patents and pricing, leaving the industry on tenterhooks. As of today, the industry seems to be struggling to keep its head above the water if recent growth figures are any indication.
Consolidation takes a breather in healthcare industry IT'S BEEN a bit of an anti-climax.
The wave of consolidation threatening to sweep over the Indian pharmaceutical industry appears to have lost momentum mid-way. The landmark decision to hand over management of Air-India and Indian Airlines to private parties, the steps taken to lease out four international airports and the bid to establish an economic regulatory authority for the civil aviation sector have made it a watershed year. Technically described as transmission and distribution losses, this is an euphemism for large-scale theft in India. Which actually brings out the extent of criminality in the transmission racket. THIS is the question whose answer could fetch you many crores.